R & D Per Annum jobs in England
Broaden your search
Refine your search
- R & D Remove selection
- GBP, Per Annum Remove selection
- Full Time 12
- Permanent 12
Found 12 jobs
-
Senior Research Scientist II - Oncology Research
Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new
New
-
Senior Protein Engineer
My client is an innovative start-up who aims to introduce an exciting era of protein production. The client is looking for a full-time, on-site ex...
-
Senior Protein Scientist
My client is an innovative start-up who aims to introduce an exciting era of protein production. The client is looking for a full-time, on-site ex...
-
Principal Software Engineer/Team Lead - Biology
A Principal/Lead Software Engineer to join a top Biotech company.
-
Head of Biology
Hobson Prior are currently looking for a Head of Biology to join a brilliant pharmaceutical organisation on a permanent basis located in Stevenage.
-
-
Head of Biology
Hobson Prior are currently looking for a Head of Biology to join a brilliant pharmaceutical organisation on a permanent basis located in Stevenage.
-
Research Scientist, Explainable AI
Research Scientist in Explainable AI to join a leading AI company to apply methods to RNA and protein biology.
-
Structural Biologist - RNA and Deep Learning
Research Scientist to work at the intersection of RNA structure and deep learning at a leading company.
-
Structural biologist – Cryo-EM
Computational Structural Biologist with Cryo-EM/ET experience to join a leading AI company
-
Principal Scientist I - Translational Medicine
Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new
-
Associate Scientist - Translational Medicine
Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new
-
Associate Director, Antibody Platform
Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new